Literature DB >> 30039158

Prediction of Cardiovascular Risk to Guide Primary Prevention.

Gregory D Curfman1.   

Abstract

Mesh：

Year:  2018        PMID： 30039158      PMCID： PMC6142962          DOI： 10.1001/jamainternmed.2018.3131

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  17 in total

Review 1.  Two decades of orphan product development.

Authors:  Marlene E Haffner; Janet Whitley; Marie Moses
Journal:  Nat Rev Drug Discov       Date:  2002-10       Impact factor: 84.694

2.  The FDA's sentinel initiative--A comprehensive approach to medical product surveillance.

Authors:  R Ball; M Robb; S A Anderson; G Dal Pan
Journal:  Clin Pharmacol Ther       Date:  2016-01-12       Impact factor: 6.875

Review 3.  Pathological laughing and crying : epidemiology, pathophysiology and treatment.

Authors:  Hal S Wortzel; Timothy J Oster; C Alan Anderson; David B Arciniegas
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

4.  What is wrong with orphan drug policies?

Authors:  André Côté; Bernard Keating
Journal:  Value Health       Date:  2012-12       Impact factor: 5.725

Review 5.  The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.

Authors:  Aaron S Kesselheim; Jerry Avorn; Ameet Sarpatwari
Journal:  JAMA       Date:  2016 Aug 23-30       Impact factor: 56.272

6.  Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial.

Authors:  Jeffrey L Cummings; Constantine G Lyketsos; Elaine R Peskind; Anton P Porsteinsson; Jacobo E Mintzer; Douglas W Scharre; Jose E De La Gandara; Marc Agronin; Charles S Davis; Uyen Nguyen; Paul Shin; Pierre N Tariot; João Siffert
Journal:  JAMA       Date:  2015 Sep 22-29       Impact factor: 56.272

7.  Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer.

Authors:  Aaron S Kesselheim; Jessica A Myers; Jerry Avorn
Journal:  JAMA       Date:  2011-06-08       Impact factor: 56.272

8.  Association of Off-label Drug Use and Adverse Drug Events in an Adult Population.

Authors:  Tewodros Eguale; David L Buckeridge; Aman Verma; Nancy E Winslade; Andrea Benedetti; James A Hanley; Robyn Tamblyn
Journal:  JAMA Intern Med       Date:  2016-01       Impact factor: 21.873

9.  Utilization of Positive and Negative Controls to Examine Comorbid Associations in Observational Database Studies.

Authors:  Jigar R Desai; Craig L Hyde; Shaum Kabadi; Matthew St Louis; Vinicius Bonato; A Katrina Loomis; Aaron Galaznik; Marc L Berger
Journal:  Med Care       Date:  2017-03       Impact factor: 2.983

10.  Development and application of two semi-automated tools for targeted medical product surveillance in a distributed data network.

Authors:  John G Connolly; Shirley V Wang; Candace C Fuller; Sengwee Toh; Catherine A Panozzo; Noelle Cocoros; Meijia Zhou; Joshua J Gagne; Judith C Maro
Journal:  Curr Epidemiol Rep       Date:  2017-10-06
View more
  1 in total

1.  Study of cardiovascular disease prediction model based on random forest in eastern China.

Authors:  Li Yang; Haibin Wu; Xiaoqing Jin; Pinpin Zheng; Shiyun Hu; Xiaoling Xu; Wei Yu; Jing Yan
Journal:  Sci Rep       Date:  2020-03-23       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.